Logo
Home|Clinics & Hospitals|Departments or Services|Insurance Companies|Health News|Contact Us
HomeClinics & HospitalsDepartments or ServicesInsurance CompaniesHealth NewsContact Us

Search

Health News

Malaria vaccine protects children for up to 18 months

Date: Oct-10-2013
Results from a large-scale Phase III African trial of an experimental malaria vaccine by GlaxoSmithKline (GSK) shows that it continued to protect young children up to 18 months after vaccination. Malaria kills 660,000 people a year, mostly children living in sub-Saharan Africa. The news about the trial results raises hopes that the first protective shot against the mosquito-borne disease will be available in 2 years. GSK says the data from the trial supports their plan to apply to the European Medicines Agency (EMA) for regulatory approval in 2014...

Adaptive Biotechnologies study reveals homogeneous immune repertoire in solid tumors

Date: Oct-10-2013
Adaptive Biotechnologies Corporation, a leading provider of next-generation oncology diagnostics, has announced results from an ovarian cancer study, conducted in collaboration with Fred Hutchinson Cancer Research Center, highlighting the even distribution of immune fighter cells (T-cells) within the tumor...

Poxel's anti-diabetic Imeglimin confirms its unique mechanism of action in type 2 diabetic patients

Date: Oct-10-2013
Poxel SA, has announced that during a human hyperglycemic clamp trial, Imeglimin, a novel compound in development to treat Type 2 diabetes, increases insulin secretion in response to glucose, confirming previous preclinical and clinical results. Imeglimin acts directly on the three main organs affected by type 2 diabetes: the pancreas, the liver and the muscle. This mechanism makes Imeglimin unique among the current anti-diabetic agents available to physicians...

Involve-visual to roll out GP video consultation service, UK

Date: Oct-10-2013
Involve Healthcare's Tele-consultation service is set to roll out its online 'GP Video' consultation service.  The announcement by Involve-visual supports the Government's plan for a radical shakeup of family doctor services and comes after David Cameron unveiled a £50m scheme to offer seven-day-a-week access to GP surgeries. In the largest reform of family doctor services in a decade, GP surgeries will be given extra resources to open from 8am to 8pm, and patients will be offered the chance of consultations through a Skype-type service...

GPs unlikely to recommend alternative duties for injured workers

Date: Oct-10-2013
Victorian General Practitioners (GPs) are more likely to order ill or injured workers stay away from work than recommend alternative duties, according to an Australian first study. Published in the prestigious Medical Journal of Australia, the study examined more than 120,000 medical certificates provided to injured workers in Victoria from 2003 to 2010. The study was a collaborative work undertaken by academics from the Institute for Safety, Compensation and Recovery Research (ISCRR) and Monash University's Department of Epidemiology and Preventative Medicine...

Epigem secures 700,000 Euros of European funding to help anaemia sufferers

Date: Oct-10-2013
Epigem, a hi-tech British company, has secured 716,000 Euros to play a leading role in the EU's CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project. Epigem's main role is to provide multifunctional microfluidic modules for blood sample preparation and multimodal measurements, design for prototyping and manufacturability based on application specifications using biocompatible materials which can be sterilised.  The company will also lead on module design and build for use on opto-fluidics microscope stage...

Larger health warnings for cigarette boxes but no slims ban, Europe

Date: Oct-10-2013
A key vote in the European Parliament means health warnings on cigarette packs will get bigger, but slim cigarettes have disappointingly not been banned...

New Zilver® PTX® drug-eluting stent study data shows excellent SFA patency results at four years

Date: Oct-10-2013
Four-year data from the Zilver® PTX® Randomized Controlled Trial of Paclitaxel-Eluting Stents for Femoropopliteal Disease from Cook Medical presented at the 2013 Vascular Interventional Advances (VIVA) meeting demonstrates 75 percent primary patency in the superficial femoral artery (SFA) at four years for patients treated with Cook Medical's paclitaxel-eluting stent. This compares to 57.9 percent patency for patients with provisional bare metal stent placement in the study...

New data on the toll technology takes on our health

Date: Oct-10-2013
LUMO BodyTech, the makers of the LUMOback smart posture and movement feedback system, has announced national survey results revealing a widespread phenomenon LUMO calls 'Silicon Valley Syndrome'. The survey revealed that 60% of Americans report having had health problems as a result of their use of technology or sitting at a desk...

Lesch-Nyhan syndrome, Alzheimer's, Parkinson's and Huntington's diseases impacted by new discovery

Date: Oct-10-2013
A research team, headed by Theodore Friedmann, MD, professor of pediatrics at the University of California, San Diego School of Medicine, says a gene mutation that causes a rare but devastating neurological disorder known as Lesch-Nyhan syndrome appears to offer clues to the developmental and neuronal defects found in other, diverse neurological disorders like Alzheimer's, Parkinson's and Huntington's diseases...